| Literature DB >> 28943631 |
Katherine E Manning1, Anthony J Holland2,3,4.
Abstract
Prader-Willi syndrome (PWS) is a neurodevelopmental disorder of genomic imprinting, presenting with a behavioural phenotype encompassing hyperphagia, intellectual disability, social and behavioural difficulties, and propensity to psychiatric illness. Research has tended to focus on the cognitive and behavioural investigation of these features, and, with the exception of eating behaviour, the neural physiology is currently less well understood. A systematic review was undertaken to explore findings relating to neural structure and function in PWS, using search terms designed to encompass all published articles concerning both in vivo and post-mortem studies of neural structure and function in PWS. This supported the general paucity of research in this area, with many articles reporting case studies and qualitative descriptions or focusing solely on the overeating behaviour, although a number of systematic investigations were also identified. Research to date implicates a combination of subcortical and higher order structures in PWS, including those involved in processing reward, motivation, affect and higher order cognitive functions, with both anatomical and functional investigations indicating abnormalities. It appears likely that PWS involves aberrant activity across distributed neural networks. The characterisation of neural structure and function warrants both replication and further systematic study.Entities:
Keywords: Prader-Willi syndrome; brain; neuroimaging; post-mortem; systematic review
Year: 2015 PMID: 28943631 PMCID: PMC5548261 DOI: 10.3390/diseases3040382
Source DB: PubMed Journal: Diseases ISSN: 2079-9721
Figure 1Article identification process for systematic literature review of neural structure and function in Prader-Willi syndrome (PWS). Literature search was carried out on 28 April 2015. Note that subcategories (e.g., case studies/series) within each main category (e.g., structural anatomy) are not mutually exclusive and references may be featured in more than one subcategory. *: One study features in both categories.
Studies reporting macrostructural anatomy in PWS.
| Author | Methods | Sample | Key findings |
|---|---|---|---|
| Cacciari | MRI—pituitary evaluation only | 1 PWS patient in larger study of 101 patients (15 y) | No abnormality found. |
| Crino | MRI—pituitary evaluation only | 8 y old male with PWS | No abnormality found. |
| Fan | Retrospective case reviews of available MRI data | MRI available for 9/10 patients with seizures from total PWS sample of 56 (31 males, 1–37 y) | MRI normal for 8/9; haemorrhage in 1/9. |
| Gilboa & Gross-Tsur 2013 [ | Retrospective case reviews of available imaging data for patients: MRI, CT, ultrasonography | Imaging data available for 59 of 125 PWS patients (50% male, 1 month–48 y): MRI for 30; CT for 17; ultrasonography for 12 | Abnormalities in 20/59, incl. 4/5 with epilepsy: including ventriculomegaly (3/59); thalamic abnormalities (3/59); partial corpus callosum agenesis (3/59); disturbed myelination (3/59); partial empty sellar (1/59). |
| Grugni | MRI—pituitary only. | 17 PWS patients (9 males, mean 20 y) | Pituitary hypoplasia (10/17); empty sella (3/17). |
| Hashimoto | MRI and 1H-MRS | 5 PWS patients (2 males, 1–14.5 y) | Abnormalities in 5/5: mild ventriculomegaly (4/5); frontal cortical atrophy (3/5); small brainstem (1/5); delayed myelination (1/5). |
| Hayashi | Post-mortem | 6 month old female with PWS | No pituitary abnormality; abnormalities of cortical gyrification, cerebellar white matter and dentate gyrus. |
| Honea | MRI | 23 participants with PWS (8 males, 10–39 y) | Deletion |
| Iughetti | Retrospective case reviews of available MRI data | 91 children with PWS (49 males, 0.7–16.8 y) | Abnormalities in 61/91: reduced pituitary height (45/91); absence of posterior pituitary bright spot (6/91); ventriculomegaly (8/91); thin corpus callosum (2/91). |
| Kumada | Retrospective case reviews of available MRI data | Imaging data available for 3/4 patients with PWS and epilepsy (1 males, 3–12 y) in larger study of chromosomal abnormalities and epilepsy | Cerebral atrophy in 1/3. |
| Leonard | MRI | 4 children with PWS (3 males, 3–10 y) | Abnormality in sylvian fissure of 1/4 PWS children (unilateral), but 6/6 AS (2 bilateral, 4 unilateral). |
| Linnemann | MRI case study | 6 y old male with PWS | Small flat pituitary; no further abnormalities. |
| Lukoshe | MRI | 20 children with PWS (9 males, 6–17 y) | Significantly reduced brainstem volume in PWS group compared to control group; trend to reduced white matter volume and total cortical surface area in PWS. |
| Lukoshe | MRI | 24 children with PWS (9 males, 6–18 y) | Decreased cortical complexity in four clusters in frontal, temporal and parietal lobes. |
| Mantoulan | MRI | 9 PWS teenagers (6 males, 12.7–18.6y, mean 16.4 y) | No abnormalities found. |
| Maski | Retrospective case reviews of available “neuroimaging” data: unspecified modality | Imaging data available for 14/21 PWS patients with seizures | Unspecified non-focal abnormalities in 3/14. |
| Miller | MRI | 15 individuals with PWS (6 males, 2–28 y) | No significant difference in pituitary height. |
| Miller | MRI | 17 PWS participants (11 males, 4–39 y) | White matter abnormalities in 6/8 adults with PWS and 5 participants with EMO, but 0/9 children with PWS and none in typically-developing controls participants. |
| Miller | MRI | 27 PWS participants (16 males, 3 m–39 y) | Incomplete insular closure in PWS, compared to both sibling and EMO control groups. |
| Miller | MRI | 20 PWS participants (12 males, 3 m–39 y) | Abnormalities in all 20 PWS participants: ventriculomegaly (20/20); incomplete closure of the insula (13/20); sylvian fissure polymicrogyria (12/20); decreased parietal-occipital volume (10/20). None of these abnormalities in either EMO or sibling control groups. |
| Miller | MRI—pituitary evaluation only | 27 individuals with PWS (16 males, 3 m–39 y) | Pituitary abnormalities in 20/27 PWS, 10/16 EMO & 2/25 controls. Abnormality not specific to PWS. |
| Miller | MRI | 16 PWS participants (10 males, mean 16.53 y) | Reduced cerebellar volume and cerebellar/cerebral ratio in PWS and EMO compared to sibling group, but no difference between PWS and EMO. |
| Ogura | MRI | 12 adults with PWS (6 males, 19–31 y) | Reduced total brain, grey matter and white matter volume, and focally reduced OFC and somatomotor area volume in PWS. |
| Stevenson | MRI and post-mortem | Post-mortem: 5 month, 9 month, & 3.5 y old with PWS (2 males) | Cortical grey & white matter abnormalities in 3/4; midbrain, hindbrain & cerebellar abnormalities in 1/4; normal in 1/4. |
| Takeshita | Retrospective case reviews of available imaging data for patients: MRI, CT | MRI available for 9/31 PWS patients with seizures (6 males, neonatal–3 y) | Diffuse atrophy in 1/9, but appears to have followed some injury to the brain of undisclosed nature. 8/9 within normal limits. |
| Tauber | Retrospective case reviews of available MRI data—pituitary only | MRI for 16/28 with PWS (mean 11.8 y) | Pituitary hypoplasia in 10/16. |
| van Nieuwpoort | MRI—pituitary only | 15 adults with PWS (4 males, 19.2–42.9 y) | Reduced anterior pituitary size in 12/15 adults with PWS compared to sibling group. |
| Vendrame | Retrospective case reviews of available MRI data | Imaging available for 20/30 PWS patients with seizures (6 males, 4–21 y) | Abnormalities in 5/20: ventriculomegaly (4/20); diffuse cortical atrophy (1/20). |
| Verrotti | Retrospective case reviews of available imaging data for patients: MRI, CT | Imaging data available for 35/28 PWS patients with seizures (22 males, seizure onset 2 days–11 y, age at imaging evaluation unspecified): MRI for 25; CT for 10 | Abnormalities in 11/35: ventriculomegaly (5/35), cortical atrophy (4/35), corpus callosum hypoplasia (1/35), periventricular leukomalacia (1/35). |
| Yamada | DTI | 8 participants with PWS (6 males, 8–29 y) | Atypical diffusivity indicating abnormalities of frontal white matter, posterior limb of internal capsule, and splenium of corpus callosum. |
| Yoshii | MRI case study | 40 week old female with PWS | Abnormal gyrification and cortical grey-white matter boundaries; partially uncovered right insula. |
AS: Angelman’s syndrome; BMI: body mass index; CSF: cerebrospinal fluid; CT: computerised tomography; DTI: diffusion tnsor imaging; EMO: early-onset morbid obesity; 1H-MRS: proton magnetic resonance spectroscopy; MRI: magnetic resonance imaging; IQ: intelligence quotient; m: months; NAA: N-acetylaspartate; OFC: orbitofrontal cortex; PFC: prefrontal cortex; PWS: Prader-Willi syndrome; UPD: uniparental disomy; y: years.
Studies reporting neural function in PWS at the macrostructural level.
| Study | Methods | Sample | Mai findings |
|---|---|---|---|
| Akefeldt | EEG: Auditory brainstem response. | 7 participants with PWS (6 males, 4–25 y) | Atypicalities of auditory brainstem response compared to control group and laboratory reference values. |
| Dimitropoulos & Schultz 2008 [ | fMRI: response to high | 9 participants with PWS (3 males, 8–38 y) | Increased amygdala, hypothalamus, insula and OFC activity when fasted in response to images of high |
| Halit | EEG: face and gaze perception. | 8 adults with deletion subtype of PWS (20–53 y) | Behavioural performance impaired for both genotypes, but ERP showed increased impairment in the deletion group: N170 amplitude larger for averted |
| Hinton | PET: pre- and post-meal (400 & 1200 kcal) response to food images. | 13 participants with PWS (22–42 y) | Increased activity in medial OFC, temporal cortex and PFC usually found not seen in PWS following meals when viewing food images. |
| Hinton | PET: response to high and low incentive food images. | 13 participants with PWS (22–42 y) | Increased activation of amygdala and medial OFC typically seen in response to high |
| Holsen | fMRI: pre- and post-meal (500 kcal) response to food images and control animal images | 9 participants with PWS (1 male, mean 14.7 y) | PWS group showed reduced activity when viewing food |
| Holsen | fMRI: pre- and post-meal (500 kcal) responses to food images and control animal images. | 9 participants with PWS deletion subtype (2 males; mean 24.4 y) | Both PWS subtypes showed atypical response in both pre- and post-meal conditions compared to control group. |
| Holsen | fMRI: pre- and post-meal 500 kcal) responses to food images and control animal images. | 14 participants with PWS (2 males, mean 23.3 y) | Pre-meal: increased activity when viewing food |
| Key & Dykens 2008 [ | EEG: N1 & P3 ERP response to food images according to categorisation/discrimination of food composition and quality. | 9 participants with deletion subtype of PWS (2 males, mean 22.9 y) | N1 ERP suggested deletion group early processing by categorising mainly according to quantity, whilst UPD did so by quality and suitability for consumption more similarly to the control group. |
| Kim | Resting-state PET while fasted. | 16 children with PWS (9 males, mean 4.2 y) | PWS group showed decreased metabolism in right superior temporal gyrus and left verebellar vermis, and increased metabolism in right OFC, bilateral medial PFC, right inferior and left superior frontal cortex, bilateral ACC, right temporal pole and left uncus. |
| Klabunde | fMRI: sessions where participants engaged in skin picking compared to sessions where they did no. | 17 participants with PWS (11 males, mean 15.7 y) | 2 main clusters showing greater activation during skin picking: right ACC & right middle frontal gyrus; primary somatosensory cortex, left inferior parietal lobule, supplementary motor area, left middle frontal gyrus and right posterior insula. |
| Mantoulan | Resting-state PET | 9 PWS teenagers (6 males; 12.7–18.6y, mean 16.4 y) | Hypoperfusion in PWS, most strongly in ACC and superior temporal regions, but also in right orbitofrontal gyrus and postcentral gyrus. |
| Miller | fMRI: response to food images following glucose load. | 8 participants with PWS (6 males, mean 25 y) | Significantly increased activity ventromedial PFC in PWS group when viewing food images following glucose load. |
| Ogura | Resting state PET | 12 participants with PWS (6 males, 19–31 y) | Decrease metabolism in PWs group in the lingual gyri, cerebellum, right thalamus and left insula. Increased metabolism in bilateral angular and inferior frontal gyri and left middle frontal gyrus. |
| Pujol | Resting state fMRI | 24 adults with PWS (12 males, mean 26.3 y) | Young adults showed sensorimotor system activity positively correlating with motion, suggesting system specific effects. Seen to some extent in children and older adults but also wider effects of motion. |
| Shapira | fMRI: before and after glucose load. | 3 participants with PWS (1 male, 25–38 y) | Delay in activation of brain areas associated in satiety response in previous study of participants without PWS, including hypothalamus, insula, ventromedial PFC and nucleus accumbens following oral glucose load. |
| Stauder | EEG: P3 ERP response to visual and auditory oddball tasks. | 10 adults with PWS (5 males, mean 30.8 y) | Markedly decreased P3 response in both visual and auditory tasks in PWS compared to control group, and most strongly for the auditory task. |
| Stauder | EEG: N200 and P300 ERPs during response inhibition on Go-Nogo task. | 11 participants with deletion subtype of PWS (7 males, mean 26.7 y) | Behavioural task performance poorer for both PWS groups compared to control group. N200 amplitude didn’t show normal peak in either PWS group, suggesting impaired early modality specific inhibition in both UPD and deletion, but only UPD group showed impaired P300 modulation, indicative of later general inhibition. |
| Woodcock | fMRI: set-shifting task. | 8 participants with PWS (5 males, mean 20.7 y) | Control group showed increased activity compared to the PWS group in frontoparietal regions during switching, including in ventromedial PFC and posterior parietal cortex. PWS tended to show ventromedial PFC deactivation instead. |
| Zhang | Resting state fMRI | 21 participants with PWS (11 males, mean 7.3 y) | ALFF greater in PWS than control group in ventrolateral PFC, ACC, inferior parietal lobe and left insula, and decreased in the medial and dorsolateral PFC, hippocampus, pre- and post-central gyri, and left OFC. |
| Zhang | Resting state fMRI | 21 participants with PWS (11 males, mean 7.3 y) | ALFF increased in PWS in ACC, hypothalamus, & left amygdala and decreased in medial PFC and right amygdala. |
ACC: anterior cingulate cortex; ALFF: amplitude of low frequency fluctuation; AS: Angelman’s syndrome; BMI: body mass index; EEG: electroencephalography; ERP: event-related potential; fMRI: functional magnetic resonance imaging; ID: intellectual disability; m: months; OFC: orbitofrontal cortex; PET: positron emission tomography; PFC: prefrontal cortex; PWS: Prader-Willi syndrome; rCBF: regional cerebral blood flow; UPD: uniparental disomy; y: years.
Studies reporting neurochemical investigations and neuroanatomy at the cellular level.
| Study | Methods | Sample | Key findings |
|---|---|---|---|
| Akefeldt | Lumbar puncture: CSF analysed for metabolites of serotonin (5-HIAA), dopamine (HVA) & noradrenaline (HMPG) | 13 participants with PWS (8 males, 0.4–23 y) | Increased levels of 5-HIAA & HVA in PWS compared to all groups, most markedly for serotonin. |
| Ebert | Venepuncture: Plasma GABA levels | 14 participants with PWS (6 males, 2–21 y) | Mean GABA levels in plasmas significantly higher (2-3 times) in both PWS and AS groups than either control group, but no significant difference between PWS and AS groups. |
| Fronczek | Post-mortem: immunocytochemistry and image analysis system estimation of orexin neuron number in the lateral hypothalamus | 7 hypothalami from individuals with PWS (3 males, 5 adults aged 25–64 y, 2 infants aged 6m & 3 y) | No difference in number of orexin neurons in hypothalamus found. |
| Goldstone | Post-mortem: immunocytochemistry & | 6 obese adults with PWS (2 males, 25–64 y) | Significant decrease of NPY and tendency to decreased NPY mRNA expression in all obese subjects, including PWS, but consistent with literature on inhibition on NPY in obesity. |
| Goldstone | Post-mortem: immunocytochemistry assessment of GHRH neuron number in infundibular nucleus/median eminence complex of the hypothalamus | 6 adults with PWS (2 males, 25–64 y) | Higher GHRH neuron number in both control adults and adults with PWS who had prolonged premorbid illness, but no difference between PWS and control or obese adults without PWS. |
| Hayashi | Post-mortem: immunohistochemical analysis of GABAergic interneurons in superior frontal cortex & OFC, ACh neurons in the nucleus basalis of Meynert & PPN, & orexin-A and vasopressin in the hypothalamus. | 6 month old female with PWS | GABAergic interneurons in cortex and ACh neurons in nucleus basalis similar in PWS and control samples. |
| Lucignani | Resting state PET: 11C-flumazenil binding to evaluate GABAA receptor functioning. | 6 participants with PWS (2 males, 19.3–29.7 y, mean 24.6 y) | Significant binding reduction (7%) in cingulate. |
| Martin | Lumbar puncture: CSF analysed for levels of oxytocin and vasopressin | 5 participants with PWS (2 males, 16–21 y) | Oxytocin levels in CSF significantly higher in PWS, especially in females. |
| Pasi | Post-mortem: immunoradiological assay of beta-endorphin levels in neural tissue | 19 y old female with PWS | No clear beta-endorphin abnormality: rank of levels of beta-endorphin in areas of the brain on which there was prior reference literature (hypothalamus, medulla, periaqueductal grey, pons, & thalamus) was very similar, with the exception of the medulla. |
| Swaab | Post-mortem: thionine and immunocytochemical staining to assess PVN size and number of oxytocin and vasopressin neurons | 5 adults with PWS (2 males, 22–64 y) | PVN significantly smaller (28%) in PWS, with total cell number reduced by 38%. |
| Talebizadeh | Post-mortem: RT-PCR evaluation of gene expression of ghrelin, peptide YY and their receptors in the frontal, temporal, and visual cortices, pons, medulla and hypothalamus | 3 individuals with PWS (0 male, 1 infant aged 1 y, 2 adults aged 32 y) | Expression detected in all brain areas in PWS, AS and control samples, with exception of PYY in pons for 1 PWS & 1 control subject. |
ACh: acetycholine; AGRP: agouti-related peptide; AS: Angelman’s syndrome; BMI: body mass index; CSF: cerebrospinal fluid; EMO: early-onset morbid obesity; GABA: gamma-aminobutyric acid; GHRH: growth hormone-releasing hormone; ID: intellectual disability; HMPG: 4-hydroxy-3-methoxyphenyl-ethylene glycol; HVA: homovanillic; m: months; mRNA: messenger ribonucleic acid; NPY: neuropeptid Y; OFC: orbitofrontal cortex; PET: positron emission tomography; PFC: prefrontal cortex; PPN: pedunculopontine nucleus: PVN: paraventricular nucleus; PWS: Prader-Willi syndrome; RT-PCR: reverse transcription polymerase chain reaction; UPD: uniparental disomy; y: years; 5-HIAA: 5-hydroxyindoleacetic acid.